$5.19 -0.04 (-0.86%)

Serina Therapeutics, Inc. (SER)

Serina Therapeutics, Inc. (SER) is a biopharmaceutical company focused on developing targeted therapies for rare and severe medical conditions, including hospital-based indications such as opioid-resistant pain. The company aims to leverage its proprietary peptide platform to develop innovative drugs that address unmet medical needs.

đźš« Serina Therapeutics, Inc. does not pay dividends

Company News

Pet's Best Life Wins “Overall Dog Health Product of the Year” For Longevity15® In 2025 Pet Innovation Awards
GlobeNewswire Inc. • Travis Grant • August 13, 2025

Pet's Best Life received the 'Overall Dog Health Product of the Year' award for Longevity15®, a supplement containing C15:0 that supports cellular health and longevity in dogs, developed in partnership with Seraphina Therapeutics.